139 related articles for article (PubMed ID: 36368769)
1. In Vivo
Tang Y; Li L; Hu T; Jiao F; Han L; Li S; Xu Z; Fan Y; Sun Y; Liu F; Yen TC; Zuo C; Wang J
Mov Disord; 2023 Jan; 38(1):147-152. PubMed ID: 36368769
[TBL] [Abstract][Full Text] [Related]
2.
Liu FT; Lu JY; Li XY; Jiao FY; Chen MJ; Yao RX; Liang XN; Ju ZZ; Ge JJ; Li G; Shen B; Wu P; Song J; Li J; Sun YM; Wu JJ; Yen TC; Luo JF; Zhao QH; Zuo C; Wang J;
Mov Disord; 2023 Apr; 38(4):579-588. PubMed ID: 36750757
[TBL] [Abstract][Full Text] [Related]
3.
Liu FT; Li XY; Lu JY; Wu P; Li L; Liang XN; Ju ZZ; Jiao FY; Chen MJ; Ge JJ; Sun YM; Wu JJ; Yen TC; Luo JF; Zuo C; Wang J;
Mov Disord; 2022 Sep; 37(9):1915-1923. PubMed ID: 35861378
[TBL] [Abstract][Full Text] [Related]
4.
Liu FT; Lu JY; Li XY; Liang XN; Jiao FY; Ge JJ; Wu P; Li G; Shen B; Wu B; Sun YM; Zhu YH; Luo JF; Yen TC; Wu JJ; Zuo CT; Wang J;
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1395-1405. PubMed ID: 36627498
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of
Lu J; Ju Z; Wang M; Sun X; Jia C; Li L; Bao W; Zhang H; Jiao F; Lin H; Yen TC; Cui R; Lan X; Zhao Q; Guan Y; Zuo C;
Eur Radiol; 2023 Jul; 33(7):4567-4579. PubMed ID: 37099173
[TBL] [Abstract][Full Text] [Related]
6. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
[TBL] [Abstract][Full Text] [Related]
7. Visual reading for [
Lin HC; Lin KJ; Huang KL; Chen SH; Ho TY; Huang CC; Hsu JL; Chang CC; Hsiao IT
Front Neurosci; 2023; 17():1148054. PubMed ID: 37250400
[TBL] [Abstract][Full Text] [Related]
8. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β and τ biomarkers in Parkinson's disease-dementia.
Buongiorno M; Compta Y; Martí MJ
J Neurol Sci; 2011 Nov; 310(1-2):25-30. PubMed ID: 21764078
[TBL] [Abstract][Full Text] [Related]
10. Human biodistribution and radiation dosimetry for the tau tracer [
Lin KJ; Huang SY; Huang KL; Huang CC; Hsiao IT
EJNMMI Radiopharm Chem; 2024 Apr; 9(1):27. PubMed ID: 38563872
[TBL] [Abstract][Full Text] [Related]
11. Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.
Buongiorno M; Antonelli F; Compta Y; Fernandez Y; Pavia J; Lomeña F; Ríos J; Ramírez I; García JR; Soler M; Cámara A; Fernández M; Basora M; Salazar F; Sanchez-Etayo G; Valldeoriola F; Barrio JR; Marti MJ
J Alzheimers Dis; 2017; 55(3):1261-1272. PubMed ID: 27814297
[TBL] [Abstract][Full Text] [Related]
12. Hypoperfusion in Alzheimer's Disease-Prone Regions and Dementia Conversion in Parkinson's Disease.
Chun MY; Lee T; Kim SH; Lee HS; Kim YJ; Lee PH; Sohn YH; Jeong Y; Chung SJ
Clin Nucl Med; 2024 Jun; 49(6):521-528. PubMed ID: 38584352
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation is linked to dementia risk in Parkinson's disease.
Kouli A; Spindler LRB; Fryer TD; Hong YT; Malpetti M; Aigbirhio FI; White SR; Camacho M; O'Brien JT; Williams-Gray CH
Brain; 2024 Mar; 147(3):923-935. PubMed ID: 37757857
[TBL] [Abstract][Full Text] [Related]
14. [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
Jokinen P; Scheinin N; Aalto S; Någren K; Savisto N; Parkkola R; Rokka J; Haaparanta M; Röyttä M; Rinne JO
Parkinsonism Relat Disord; 2010 Dec; 16(10):666-70. PubMed ID: 20870446
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
[TBL] [Abstract][Full Text] [Related]
16. In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
Hansen AK; Damholdt MF; Fedorova TD; Knudsen K; Parbo P; Ismail R; Østergaard K; Brooks DJ; Borghammer P
Mov Disord; 2017 Jun; 32(6):922-927. PubMed ID: 28256006
[TBL] [Abstract][Full Text] [Related]
17. Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis.
Zhang J; Jin J; Su D; Feng T; Zhao H
Front Neurol; 2023; 14():1145939. PubMed ID: 37181568
[TBL] [Abstract][Full Text] [Related]
18. In Vivo
Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J
Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301
[TBL] [Abstract][Full Text] [Related]
19. [Cerebral glucose metabolism in Parkinson's disease with dementia].
Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710
[TBL] [Abstract][Full Text] [Related]
20. Misery Perfusion and Tau Deposition in Atherosclerotic Major Cerebral Artery Disease: A
Yamauchi H; Kagawa S; Kusano K; Ito M; Okuyama C
Stroke; 2022 Dec; 53(12):e500-e503. PubMed ID: 36337055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
